DXCM : Insider Transactions for DexCom Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

DexCom Inc (DXCM)

$67.53

0.80 (1.2%) as of 4:30 Thu 9/26

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

389,580,000

Market Cap:

26.31(B)

Last Volume:

3,294,635

Avg Vol:

2,072,018

52 Week Range:

$64 - $140.45

Level I Sector:

Health Care

Level II Sector:

Health Services

Level III Sector:

Medical Instruments & Supplies

Member Indexes:

NASDAQ COMPOSITE

NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 520

Guru Rank Value : 3.6

Guru Occurances : 3


6 Months 1 Year 2 Year

Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	4,915	71,783	301,616	583,537
Total Sell Value	$371,314	$9,377,154	$39,059,786	$70,857,495
Total People Sold	5	8	14	16
Total Sell Transactions	7	19	46	88
End Date	2024-06-27	2024-03-26	2023-09-26	2022-09-26

Adjust Filter Settings

Records found: 2316

Page 29 of 93

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Director

– • –

2019-01-02

4

OE

$4.58

$118,191

I/I

25,806

52,616

-

Doubleday Richard

EVP, Chief Commercial Officer

• – –

2018-12-21

4

AS

$108.23

$165,101

I/I

(1,510)

14,112

-

Pacelli Steven Robert

EVP, Strategy & Corp. Dev.

• – –

2018-12-21

4

AS

$108.24

$340,700

D/D

(3,114)

104,518

-

EVP, Reg. Strategy, Clinical

• – –

2018-12-14

4

AS

$120.23

$606,167

D/D

(5,000)

73,105

-

Murphy Patrick Michael

SVP, GC & Chief Compliance Off

• – –

2018-12-10

4

AS

$121.90

$48,760

D/D

(400)

30,108

-

President, CEO & Chairman

• • –

2018-12-10

4

AS

$120.39

$1,358,041

D/D

(11,162)

320,837

-

President, CEO & Chairman

• • –

2018-12-10

4

OE

$4.58

$51,122

D/D

11,162

331,999

-

Doubleday Richard

EVP, Chief Commercial Officer

• – –

2018-11-23

4

AS

$119.74

$210,664

I/I

(1,736)

15,622

-

Pacelli Steven Robert

EVP, Strategy & Corp. Dev.

• – –

2018-11-23

4

AS

$119.82

$378,105

D/D

(3,114)

107,632

-

EVP, Reg. Strategy, Clinical

• – –

2018-11-14

4

AS

$141.25

$715,664

D/D

(5,000)

78,105

-

President, CEO & Chairman

• • –

2018-11-12

4

AS

$142.25

$1,634,284

D/D

(11,161)

320,837

-

President, CEO & Chairman

• • –

2018-11-12

4

OE

$4.58

$51,117

D/D

11,161

331,998

-

SVP Human Resources

• – –

2018-11-09

4

AS

$145.91

$627,294

D/D

(4,258)

65,081

-

EVP, Quality & Regulatory Afrs

• – –

2018-11-09

4

AS

$147.62

$1,575,159

D/D

(10,550)

88,089

-

Murphy Patrick Michael

SVP, GC & Chief Compliance Off

• – –

2018-11-09

4

AS

$148.11

$59,244

D/D

(400)

30,508

-

Doubleday Richard

EVP, Chief Commercial Officer

• – –

2018-10-23

4

AS

$128.66

$223,466

I/I

(1,736)

17,358

-

Pacelli Steven Robert

EVP, Strategy & Corp. Dev.

• – –

2018-10-23

4

AS

$128.61

$401,253

D/D

(3,114)

110,746

-

EVP, Reg. Strategy, Clinical

• – –

2018-10-12

4

AS

$124.49

$623,934

D/D

(5,000)

83,105

-

Murphy Patrick Michael

SVP, GC & Chief Compliance Off

• – –

2018-10-10

4

AS

$122.20

$48,880

D/D

(400)

30,908

-

President, CEO & Chairman

• • –

2018-10-08

4

AS

$124.32

$1,392,433

D/D

(11,161)

320,837

-

President, CEO & Chairman

• • –

2018-10-08

4

OE

$4.58

$51,117

D/D

11,161

331,998

-

Altman Steven R

Director

– • –

2018-10-01

4

AS

$132.68

$339,134

I/I

(2,500)

55,355

-

Leach Jacob Steven

Chief Technology Officer

• – –

2018-09-28

4

AS

$142.96

$6,852,139

I/I

(47,600)

0

-

Pacelli Steven Robert

EVP, Strategy & Corp. Dev.

• – –

2018-09-24

4

AS

$138.69

$439,841

D/D

(3,114)

113,860

-

Doubleday Richard

EVP, Chief Commercial Officer

• – –

2018-09-24

4

AS

$138.25

$245,129

I/I

(1,736)

19,094

-

2316 Records found	Previous 20 21 22 23 24 25 26 27 28 29 Next	Page 29 of 93

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.